Release Date: 29/01/14 12:07 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 1.54MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%